Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
A single-center, non-interventional prospective observational study in the NSCLC patients with different driver genes
The trial was designed as a single-center non-interventional prospective observational study to explore clinical treatments of the NSCLC patients with different driver genes, the impact factors of patient survivals, and the relevance of gene types, clinical treatments, and distribution of gene types. The follow-up visits, interactions between the investigators and patients, patient questionnaires/quality of life, and other patient information will be uploaded via mobile APP, and webchat every three months.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| NSCLC patients with driver genes | NSCLC patients and driver genes |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Patients with driver genes | Other | Patients with driver genes |
|
| Measure | Description | Time Frame |
|---|---|---|
| Differences in overall survival rates | Differences in overall survival rates of the NSCLC patients with various gene types | 2018-2022 |
| Measure | Description | Time Frame |
|---|---|---|
| Interaction impact between gene types and treatment modalities or regimens on disease-free survivals | Interaction impact between gene types and treatment modalities or regimens on disease-free survivals | 2018-2022 |
| Statuses of clinical treatment regimens |
Not provided
Inclusion Criteria:
Exclusion Criteria:
-None
Not provided
Not provided
Not provided
The pathologically diagnosed patients with non-small cell lung cancer who were performed with NGS technology
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Jianxing HE, MD | Contact | 00862083062114 | hejx@vip.163.com | |
| Wenhua LIANG, Ph.D | Contact | 00862083062114 | liangwh1987@163.com |
| Name | Affiliation | Role |
|---|---|---|
| Wenhua Liang, Ph.D | The First Affiliated Hospital of Guangzhou Medical University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Wenhua of Liang | Recruiting | Guangzhou | Guangdong | 510120 | China |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D002289 | Carcinoma, Non-Small-Cell Lung |
| ID | Term |
|---|---|
| D002283 | Carcinoma, Bronchogenic |
| D001984 | Bronchial Neoplasms |
| D008175 | Lung Neoplasms |
| D012142 | Respiratory Tract Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
Statuses of clinical treatment regimens of the NSCLC patients |
| 2018-2022 |
| Relevance of gene types | Relevance of gene types and clinical characteristics of the NSCLC patients | 2018-2022 |
| Relevance of overall survival rates and gene types | Relevance of overall survival rates and gene types of the NSCLC patients | 2018-2022 |
| Impacts of disease-free survivals on gene types | Impacts of disease-free survivals on gene types of the NSCLC patients | 2018-2022 |
| Impacts of progression-free survivals | Impacts of progression-free survivals on gene types of the NSCLC patients | 2018-2022 |
| Impact factors of overall survivals | Impact factors of overall survivals of the NSCLC patients | 2018-2022 |
| D013899 |
| Thoracic Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |